Skip to main content
. 2020 Apr 8;15:75. doi: 10.1186/s13014-020-01518-2

Table 3.

Radiological response to treatment at 4–6 weeks after the concurrent chemoradiotherpay

Response Overall III IVa IVb Recurrences
CR 21 (38.9) 8 (14.8) 3 (5.6) 3 (5.6) 7 (13.0)
PR 21 (38.9) 5 (9.3) 3 (5.6) 7 (13.0) 6 (11.1)
SD 7 (13.0) 1 (1.9) 0 3 (5.6) 3 (5.6)
PD 3 (5.6) 0 0 1 (1.9) 2 (3.7)
Missing 2 (3.7) 0 1 (1.9) 1 (1.9) 0
Total 54 (100.0) 14 (25.9) 7 (13.0) 15 (27.8) 18 (33.3)